Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus

PHASE2TerminatedINTERVENTIONAL
Enrollment

273

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

October 27, 2022

Study Completion Date

October 31, 2022

Conditions
Type1 Diabetes Mellitus
Interventions
DRUG

Hydroxychloroquine

Hydroxychloroquine for oral administration, dosed by weight

DRUG

Placebo

Placebo tablet identical to active drug

Trial Locations (51)

2065

Royal North Shore Hospital, St Leonards

3052

Walter and Eliza Hall Institute of Medical Research, Parkville

5006

Women's and Children's Hospital, Adelaide, North Adelaide

6840

Perth Children's Hospital, Perth

10032

Columbia University, New York

13210

Joslin Center at SUNY Upstate Medical University, Syracuse

14203

UBMD Pediatrics, Buffalo

15224

University of Pittsburgh, Pittsburgh

20132

San Raffaele Hospital, Milan

20502

Skane University Hospital, Malmo

22908

University of Virginia Health System, Charlottesville

29605

Endocrinology Specialist / Greenville Health System, Greenville

29615

GHS - Pediatric Endocrinology, Greenville

30322

Emory Children's Center, Atlanta

32610

University of Florida, Gainesville

33136

University of Miami, Miami

33612

USF Diabetes Center, Tampa

37232

Vanderbilt Eskind Diabetes Clinic, Nashville

40202

University of Louisville Pediatric Endocrinology, Louisville

40504

University of Kentucky/UK Healthcare, Lexington

44195

Cleveland Clinic Foundation, Cleveland

46202

Indiana University - Riley Hospital for Children, Indianapolis

48109

University of Michigan Health System, Ann Arbor

52242

University of Iowa, Iowa City

53226

Medical College of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

57105

Sanford Children's Specialty Clinic, Sioux Falls

60637

University of Chicago, Chicago

64108

The Children's Mercy Hospital, Kansas City

73104

The University of Oklahoma, Oklahoma City

75390

University of Texas Southwestern, Dallas

80045

Barbara Davis Center, Aurora

83404

Rocky Mountain Clinical Research, Idaho Falls

83702

St. Luke's Humphreys Diabetes Center, Boise

84132

University of Utah, Salt Lake City

89148

Palm Research Center, Inc., Las Vegas

90027

Children's Hospital Los Angeles, Los Angeles

94143

University of California - San Francisco, San Francisco

94305

Stanford University, Stanford

98101

Benaroya Research Institute, Seattle

06519

Yale University School of Medicine, New Haven

02215

Joslin Diabetes Center, Boston

19104-4399

Childrens Hospital of Philadelphia, Philadelphia

K1H8L1

Children's Hospital of Eastern Ontario, Ottawa

M5G-1X8

The Hospital For Sick Kids, Toronto

NS B3K 6R8

IWK Health Center, Halifax

EX2 5DW

Royal Devon and Exeter Hospital, Exeter

PLG8BX

Plymouth Diabetes Clinical Research Unit, Plymouth

HG2 7SX

Harrogate and District NHS Foundation Trust, Harrogate

BS10 5NB

University of Bristol, Bristol

NG7 2UH

Nottingham University Hospitals, Nottingham

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH